Filter by: patients
Home > Community Treatment Reports and Side Effects > Golimumab Treatment Report
What is Golimumab?

Golimumab is an antipsoriatic, antirheumatic monoclonal antibody. It is used for the treatment of active rheumatoid arthritis (moderate-to-severe), active psoriatic arthritis, and active ankylosing spondylitis.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
RA (Rheumatoid Arthritis) 12 0
Rheumatoid Arthritis 4 2 Efficacy_major Efficacy_cant_tell
Ankylosing Spondylitis 3 1 Efficacy_cant_tell
Psoriatic Arthritis 3 1 Efficacy_moderate

See all 23 patients currently taking Golimumab

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 1
Mild
 1
None
 1

Commonly reported side effects, conditions, and hospitalizations associated with Golimumab

Bruising 1
Lumps and bumps 1
Psoriasis on face 1
Psoriasis 1

Reported Dosages

  50mg/0.5mL as needed 50 mg/0.5 mL monthly 50 mg/0.5 mL every other week 50 mg/0.5 mL daily
  1 Number of Patients: 1 20 Number of Patients: 20 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Golimumab (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 2   Side effects too severe: 67%
Expense 1   Expense: 33%
Personal research 1   Personal research: 33%
Course of treatment ended 1   Course of treatment ended: 33%

See all 3 patients who’ve stopped taking Golimumab

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Golimumab

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Stopped Taking Golimumab

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Golimumab

Always
 3 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Golimumab

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 3 100%

Cost

Paid out of pocket

Cost of Golimumab

$200+
 1 33%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 2 67%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.